Profiel
Emmanuel Caeymaex is currently Executive Vice President-Patient Evidence at UCB SA since 1994.
Former positions include Director at Dermira, Inc. in 2017 and President at UCB Japan Co. Ltd. from 2006 to 2011.
Education includes graduate degrees from Université Catholique de Louvain and CEMS.
The Global Alliance in Management Education.
Actieve functies van Emmanuel Caeymaex
| Bedrijven | Functie | Begin |
|---|---|---|
| UCB | Corporate Officer/Principal | 01-03-1994 |
Eerdere bekende functies van Emmanuel Caeymaex
| Bedrijven | Functie | Einde |
|---|---|---|
| DERMIRA, INC. | Directeur/Bestuurslid | 06-11-2017 |
UCB Japan Co. Ltd.
UCB Japan Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | President | 01-06-2011 |
Opleiding van Emmanuel Caeymaex
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB Japan Co. Ltd.
UCB Japan Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
CEMS The Global Alliance in Management Education
CEMS The Global Alliance in Management Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















